IL78872A0 - Morphinan derivatives and pharmaceutical compositions containing them - Google Patents

Morphinan derivatives and pharmaceutical compositions containing them

Info

Publication number: IL78872A0
Authority: IL; Israel
Prior art keywords: pharmaceutical compositions; compositions containing; morphinan derivatives; morphinan; derivatives
Prior art date: 1985-05-23

Application number

IL78872A

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-05-23

Filing date

1986-05-21

Publication date

1986-09-30

1986-05-21 Application filed by Sandoz Ag filed Critical Sandoz Ag

1986-09-30 Publication of IL78872A0 publication Critical patent/IL78872A0/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Obesity (AREA)
Addiction (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

IL78872A 1985-05-23 1986-05-21 Morphinan derivatives and pharmaceutical compositions containing them IL78872A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3518525		1985-05-23

Publications (1)

Publication Number	Publication Date
IL78872A0 true IL78872A0 (en)	1986-09-30

Family

ID=6271435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL78872A IL78872A0 (en)	1985-05-23	1986-05-21	Morphinan derivatives and pharmaceutical compositions containing them

Country Status (18)

Country	Link
JP (1)	JPS61271275A (en)
AU (1)	AU594954B2 (en)
BE (1)	BE904796A (en)
DK (1)	DK240386A (en)
ES (1)	ES8802318A1 (en)
FI (1)	FI862124A (en)
FR (1)	FR2582309B1 (en)
GB (1)	GB2175898B (en)
GR (1)	GR861318B (en)
HU (1)	HU196376B (en)
IL (1)	IL78872A0 (en)
IT (1)	IT1203791B (en)
LU (1)	LU86435A1 (en)
NL (1)	NL8601188A (en)
NZ (1)	NZ216250A (en)
PH (1)	PH23341A (en)
SE (1)	SE8602308L (en)
ZA (1)	ZA863873B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4857533A (en) *	1988-12-15	1989-08-15	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for autoimmune diseases
US4863928A (en) *	1989-01-04	1989-09-05	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for arthritic and inflammatory diseases
US4923875A (en) *	1989-07-10	1990-05-08	Baker Cummins Pharmaceuticals, Inc.	Method for treatment of mast cell-mediated dermatologic disorders
JP2906654B2 (en) *	1989-11-28	1999-06-21	東レ株式会社	Immunosuppressant and method for producing the same
US5057322A (en) *	1990-08-10	1991-10-15	Baker Cummins Dermatologicals, Inc.	Method of treating mast cell disease
JP2525552B2 (en)	1992-01-23	1996-08-21	東レ株式会社	Morphine derivative and pharmaceutical use
EP0661283B1 (en) *	1993-07-19	1998-10-21	Toray Industries, Inc.	Brain cell protective
NZ268969A (en) *	1993-07-23	1997-06-24	Toray Industries	Morphinan derivatives and pharmaceutical compositions
AR005423A1 (en)	1996-01-10	1999-06-23	Smithkline Beecham Spa	MORPHINOID DERIVATIVES CONDENSED WITH HETERO CYCLES (II), THEIR USE AS A THERAPEUTIC SUBSTANCE AND TO PREPARE MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE TO PREPARE SUCH DERIVATIVES.
EP1312361A1 (en) *	1996-11-25	2003-05-21	Toray Industries, Inc.	Antipruritic agent
AU6117298A (en) *	1997-07-25	1999-02-16	Toray Industries, Inc.	Hyponatremia remedies
US7501433B2 (en)	2002-05-17	2009-03-10	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
WO2003097608A2 (en)	2002-05-17	2003-11-27	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
US7923454B2 (en)	2002-05-17	2011-04-12	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
JP4957489B2 (en) *	2002-10-09	2012-06-20	東レ株式会社	Pharmaceutical containing morphinan derivative having nitrogen-containing cyclic substituent or pharmacologically acceptable acid addition salt thereof
US8017622B2 (en)	2003-05-16	2011-09-13	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
AU2009214500B2 (en) *	2008-02-14	2014-10-23	Alkermes, Inc.	Selective opioid compounds
US8980906B2 (en) *	2012-12-14	2015-03-17	Purdue Pharma L.P.	Pyridonemorphinan analogs and biological activity on opioid receptors
JP6141444B2 (en) *	2012-12-14	2017-06-07	パーデュー、ファーマ、リミテッド、パートナーシップ	Spirocyclic morphinans and their use
AR096851A1 (en) *	2013-07-11	2016-02-03	H Lundbeck As	SALTS THAT DO NOT FORM HYDRATS OR SOLVATOS DE NALMEFENO
WO2015192053A1 (en) *	2014-06-13	2015-12-17	Purdue Pharma L.P.	Azamophinan derivatives and use thereof

1986
- 1986-05-09 HU HU861934A patent/HU196376B/en not_active IP Right Cessation
- 1986-05-12 NL NL8601188A patent/NL8601188A/en not_active Application Discontinuation
- 1986-05-19 GB GB8612159A patent/GB2175898B/en not_active Expired
- 1986-05-19 PH PH33785A patent/PH23341A/en unknown
- 1986-05-21 NZ NZ216250A patent/NZ216250A/en unknown
- 1986-05-21 ES ES555200A patent/ES8802318A1/en not_active Expired
- 1986-05-21 GR GR861318A patent/GR861318B/en unknown
- 1986-05-21 FI FI862124A patent/FI862124A/en not_active Application Discontinuation
- 1986-05-21 AU AU57637/86A patent/AU594954B2/en not_active Expired - Fee Related
- 1986-05-21 SE SE8602308A patent/SE8602308L/en not_active Application Discontinuation
- 1986-05-21 BE BE1/011493A patent/BE904796A/en not_active IP Right Cessation
- 1986-05-21 IL IL78872A patent/IL78872A0/en unknown
- 1986-05-22 JP JP61118984A patent/JPS61271275A/en active Pending
- 1986-05-22 DK DK240386A patent/DK240386A/en not_active Application Discontinuation
- 1986-05-22 LU LU86435A patent/LU86435A1/en unknown
- 1986-05-23 FR FR8607367A patent/FR2582309B1/en not_active Expired
- 1986-05-23 ZA ZA863873A patent/ZA863873B/en unknown
- 1986-05-23 IT IT48050/86A patent/IT1203791B/en active

Also Published As

Publication number	Publication date
IT8648050A0 (en)	1986-05-23
GB8612159D0 (en)	1986-06-25
LU86435A1 (en)	1986-12-05
HU196376B (en)	1988-11-28
JPS61271275A (en)	1986-12-01
HUT41737A (en)	1987-05-28
FR2582309B1 (en)	1989-08-18
ZA863873B (en)	1988-01-27
GB2175898B (en)	1989-07-05
SE8602308D0 (en)	1986-05-21
DK240386A (en)	1986-11-24
PH23341A (en)	1989-07-14
SE8602308L (en)	1986-11-24
AU594954B2 (en)	1990-03-22
FI862124A (en)	1986-11-24
GB2175898A (en)	1986-12-10
FR2582309A1 (en)	1986-11-28
NL8601188A (en)	1986-12-16
ES8802318A1 (en)	1988-05-01
FI862124A0 (en)	1986-05-21
AU5763786A (en)	1986-11-27
ES555200A0 (en)	1988-05-01
BE904796A (en)	1986-11-21
GR861318B (en)	1986-09-19
IT1203791B (en)	1989-02-23
NZ216250A (en)	1990-04-26
DK240386D0 (en)	1986-05-22

Publication	Publication Date	Title
NZ216793A (en)	1990-05-28	Phenethanolaminotetraline derivatives and pharmaceutical compositions
NZ217931A (en)	1989-04-26	Pyridone derivatives and pharmaceutical compositions
NZ220345A (en)	1990-10-26	Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ216678A (en)	1989-10-27	Heterocyclic substituted-phenoxyalkyl-isoxazoles and -furans and pharmaceutical compositions
IL78872A0 (en)	1986-09-30	Morphinan derivatives and pharmaceutical compositions containing them
IL74865A0 (en)	1985-07-31	9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
IL79376A0 (en)	1986-10-31	Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL82205A (en)	1991-05-12	Substituted alkane-sulfonamidophenyl derivatives and pharmaceutical compositions containing them
IL76188A (en)	1990-11-29	3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
NZ220336A (en)	1990-10-26	Isoquinoline derivatives and pharmaceutical compositions containing such
NZ214821A (en)	1989-03-29	Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ218428A (en)	1989-03-29	Heterocyclically-substituted quinoline derivatives and pharmaceutical compositions
NZ217220A (en)	1989-10-27	Guanine derivatives and pharmaceutical compositions
NZ216416A (en)	1989-01-06	Benzazepine derivatives and pharmaceutical compositions
NZ217078A (en)	1989-01-27	N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ216894A (en)	1989-09-27	Penicillin derivatives and pharmaceutical compositions
IL86711A0 (en)	1988-11-30	5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them
NZ216720A (en)	1990-09-26	Diazinylpiperidine derivatives and pharmaceutical compositions
GB2167414B (en)	1989-01-11	Flavolignan derivatives and pharmaceutical compositions containing them
NZ215070A (en)	1988-08-30	Imidazole-indoles and pharmaceutical compositions
NZ218098A (en)	1989-07-27	Imidazole derivatives and pharmaceutical compositions
IL80540A0 (en)	1987-02-27	Dihydropyridine derivatives and pharmaceutical compositions containing them
IL79003A0 (en)	1986-09-30	Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
NZ216438A (en)	1989-01-06	Steroid-pyrazoles and pharmaceutical compositions
PH24135A (en)	1990-03-05	Quinoline derivatives and pharmaceutical composition containing said compounds